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Abstract
Introduction: Memory impairment is one of the most commonly reported effects of cannabis use, especially
among those who initiate use earlier, perhaps due to the effects of delta-9- tetrahydrocannabinol on cannabi-
noid (CB1) receptors in the brain. Studies have increasingly investigated whether cannabis use is associated with
impairments in verbal memory, and with alterations in brain structures underlying verbal memory. The uncinate
fasciculus (UF), a long-range white matter tract, connects regions with densely localized CB1 receptors that are
important in verbal memory. This study investigated the impact of cannabis use on UF structures and its asso-
ciation with memory performance in young adult cannabis users (CU) and non-using controls (CON).
Materials and Methods: Nineteen CU and 22 CON completed a verbal memory task and a neuroimaging pro-
tocol, in which diffusion tensor imaging and structural scans were collected. We compared memory perfor-
mance, diffusion and tractography measures of the UF, and cortical thickness of regions connected by the
UF, between CU and CON. In regions showing a signiﬁcant group effect, we also examined associations between
verbal memory performance, cortical thickness, and age of onset of cannabis use.
Results: Compared to non-users, CU had worse memory performance, decreased ﬁber bundle length in the UF,
and decreased cortical thickness of brain regions along the UF such as the entorhinal cortex and fusiform gyrus.
Verbal memory performance was signiﬁcantly associated with age of onset of cannabis use, indicating that those
who initiated cannabis use at an earlier age performed worse. Cortical thickness of the entorhinal cortex was
signiﬁcantly correlated with age of ﬁrst use and memory performance.
Conclusion: This study provides evidence that cannabis use, especially when initiated at a young age, may be
associated with worse verbal memory and altered neural development along the UF. Reductions in cortical thick-
ness in regions implicated in memory processes may underlie weaknesses in verbal memory performance.
Keywords: addiction; cannabis; cortical thickness; diffusion tensor imaging; fractional anisotropy; mean diffusivity;
verbal memory
Introduction
Cannabis is the most commonly used illicit drug
among young adults in the United States with
19.8% of 18–25 year olds reporting use in the past
month.1 Cannabis use has been associated with def-
icits in several aspects of memory,2 particularly
with impairments in verbal memory (i.e., memory
for words and verbal, rather than spatial, items).3–9
Moreover, cannabis use has been related to changes
in brain structure, especially among those with an
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earlier age of cannabis initiation (for reviews, see
Refs.10–13).
Delta-9-tetrahydrocannabinol (THC), the main psy-
choactive compound in cannabis, binds to endogenous
cannabinoid (CB1) receptors located in brain regions
known to support verbal memory, including the fusi-
form gyrus, entorhinal cortex, and temporal pole,14,15
as well as in other connecting regions that are involved
in manipulating and integrating information, such as
the inferior temporal lobe and the orbitofrontal cortex
(OFC).16,17 These structures are connected by the unci-
nate fasciculus (UF), a crescent shaped, monosynaptic,
bidirectional long-range ﬁber bundle18,19 (see Fig. 1A
for illustration). The UF and its interconnected struc-
tures support encoding and retrieval aspects of verbal
memory,20 which may be impaired among cannabis
users (CU).21–24 To our knowledge, studies have not
examined potential differences between CU and non-
using controls in white matter integrity of UF, cortical
thickness of the regions it connects, and their relation-
ship to memory performance.
Generally, cannabis-related alterations in brain
structure are greater in individuals with an earlier
age of cannabis initiation.25,26 Adolescent cannabis
exposure has also been associated with compromised
white matter integrity,27–31 including microstructural
abnormalities in the splenium of the corpus callosum
and the fornix.32,33 Memory impairment is also greater
among those with an earlier age of onset of use.
Heavy CU show a variety of memory deﬁcits, includ-
ing poorer immediate and delayed recall,21–24,34 and
the degree of memory impairments has been asso-
ciated with duration, quantity, and age of onset of
cannabis use.24 Our laboratory has extended these
ﬁndings, reporting that early adolescent onset of can-
nabis use (e.g., use before the age of 16) is associated
with greater verbal memory impairments due to
weaknesses in encoding.35
FIG. 1. (A) Visualization of the bilateral uncinate fasciculus connecting the orbitofrontal poles, temporal poles,
entorhinal cortex, fusiform gyri, and inferior temporal gyri, among all participants, using TRACULA. (B)
Scatterplot of ﬁber bundle length for the left and right hemisphere for CU and CON. There was a signiﬁcant
reduction in ﬁber bundle length in the UF in CU compared to controls. CU, cannabis users; UF, uncinate fasciculus.
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Studies have separately shown that cannabis use may
reduce cortical thickness36 or impair memory perfor-
mance,22–24,34,37 but few have evaluated the relationship
between cannabis-related changes in brain structure and
memory performance. Generally, there is poor evidence
for robust associations between measures of brain mor-
phology and neurocognitive performance (see Ref. 38
for review), although a handful of studies have demon-
strated this link (e.g., see Refs. 39 and 40). In this
study, we investigated memory performance and struc-
tural measures of brain regions implicated in memory
in young adult CU, and associated these factors with
the age of onset of cannabis use. Speciﬁcally, we used dif-
fusion tensor imaging (DTI) imaging, tractography, and
structural analyses to examine directional coherence
and ﬁber bundle length of the UF, as well as cortical thick-
ness of regions connected by the UF. We had three main
hypotheses: (1) verbal memory performance would be
signiﬁcantly worse in CU compared to CON, (2) direc-
tional coherence and ﬁber bundle length of the UF,
as well as cortical thickness of the regions connected by
the UF (e.g., medial and lateral parts of OFC, the fusiform
gyri, the entorhinal cortex, and the inferior temporal pole),
wouldbedifferent inCUcompared toCON, and (3)worse
memory performance would be more pronounced in the
CU group among those with an earlier age of cannabis ini-
tiation. As a post-hoc, exploratory analyses, we also inves-
tigated correlations among structural measures, verbal
memory performance, and age of cannabis initiation.
Materials and Methods
Participants
Forty-one young adults between 18 and 25 years
(M= 21.12; SD= 2.26) participated in this study. Nine-
teen (8 male and 11 female) were recreational CU and
22 (10 male, 12 female) were non-using controls
(CON) (Table 1). Participants were medically healthy,
and did not meet Diagnostic and Statistical Manual
of Mental Disorders, 4th Edition (DSM-IV) criteria for
any current or lifetime Axis I disorders according to
the Structural Clinical Interview of the DSM-IV Disor-
ders (SCID-4) (except for cannabis abuse or dependence
in the CU group). CU and CON were matched on age,
gender, handedness, race, and years of education. All
participants were right handed. Participants completed
the AUDIT (Alcohol Use Disorder Identiﬁcation
Test)41 to assess alcohol drinking behaviors. No partici-
pant met criteria for hazardous drinking behavior, de-
ﬁned by scores above 16, and none were regular
cigarette smokers. CU participants used cannabis at
least once a week (M= 5.87 joints/week). Past experi-
mental use of other illegal drugs did not lead to exclu-
sion; however, participants were excluded from the
study if they had ever met abuse criteria for any other
drug than cannabis. Three CU reported illicit drug use:
one reported cocaine use, one reported ecstasy use, and
one reported use of cocaine, mushrooms, lysergic acid
diethylamide, and N,N-dimethyltryptamine. No partici-
pant reported any drug use of more than ﬁve times in
their lifetime. CON were included in this study if they
had not used cannabis in the past 6 months, and had
used cannabis on less than ﬁve occasions in their lifetime.
All participants gave written informed consent and were
compensated for their time. Experiments were approved
by the Partners Human Research Committee Institu-
tional Review Board at Massachusetts General Hospital.
Procedures. Participants completed two study visits: a
screening visit, inwhich they completed cognitive testing,
and a second study visit in which they underwent a neu-
roimaging session. All CU were asked to refrain from
using substances on study days, but were permitted to
use cannabis up until the night before the study (to reduce
possible withdrawal effects). We performed a urine drug
screen to test for cannabis, amphetamines, cocaine, barbi-
turates, methamphetamines, benzodiazepines, codeine,
morphine, and ethanol. SinceTHC-COOH, themain sec-
ondary metabolite of tetrahydrocannabinol, can still
be detected in urine up to several weeks after last use,
we used a four-item cannabis intoxication scale42 to
rule out acute intoxication. Acute intoxication was de-
termined based on the following criteria: increased
resting heart rate (100 beats per minute), congestions
of the conjunctival blood vessels (red eyes), slowed
speech responses, and giddiness. No participants met
criteria for acute intoxication. CU participants were
asked to complete a timeline followback questionnaire43
to retroactively establish the number of days that they
Table 1. Participant Demographics
Cannabis users
(n= 19)
Controls
(n = 22)
Gender (m/f) 8/11 10/12
Age (years) 20.58 (2.52) 21.59 (1.94)
Years of education 14.16 (1.80) 15.05 (1.56)
No. of alcoholic drinks/week* 3.03 (2.14) 1.90 (2.33)
Cannabis use (days/week) 2.70 (1.48) n/a
No. of joints/week 5.87 (7.36) n/a
No. of days from last cannabis use 2.79 (3.10) n/a
Age of first cannabis use (years) 16.21 (1.69) n/a
Duration of use (years) 4.37 (1.67) n/a
All values are means and standard deviations.
*p< 0.05.
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used cannabis, as well as the number of joints they
smoked per occasion, and the number of smoking events
per day, for the past 90 days. Both CU and CON also
completed a timeline followback questionnaire assessing
alcohol use and drinking behavior over the past 90 days.
Memory testing. All participants completed the Cali-
fornia Verbal Learning Test Second Edition (CVLT-II;
Ref.44), which involves verbal presentation of a 16-
word list consisting of 4 nonadjacent words from four
different semantic categories (i.e., vegetables, modes of
travel, animals, and furniture). The list is presented ﬁve
consecutive times, and participants recalled the words
after each learning trial. After a 20-min delay, partici-
pants recalled as many words as they could remember.
Primary outcome variables included the following: short
delayed free recall (SDFR; total words freely recalled im-
mediately; range: 0–16), long delayed free recall (LDFR;
total words freely recalled after a 20-min delay; range:
0–16), short delayed cued recall (SDCR; total words
recalled immediately when presented with cued catego-
ries; range: 0–16), and long delayed cued recall (LDCR;
total words recalled after a 20-min delay with cued cate-
gories; range: 0–16). We also computed scores for Trial 1
recall, total learning, learning slope, and semantic and se-
rial clustering. Raw scores were converted to standardized
scores for analyses.
Image acquisition and analyses. Neuroimaging data
were acquired using a 3T Siemens (Erlangen/Germany)
Trio scanner with a 32-channel head coil at the Marti-
nos Center for Biomedical Imaging. Whole-brain T1-
weighted 1mm isotropic structural scans were collected
using a 3D multi-echo MPRAGE sequence (176 sagittal
slices, 256mm FoV, repetition time (TR)= 2530msec,
TI= 1200msec, 2 ·GRAPPA acceleration, echo time
(TE) = 1.64/3.5/5.26/7.22msec, BW 651Hz/px, Tacq=
6.03min).45 Diffusion-weighted images were acquired
using single spin-echo echo-planar imaging (EPI) with
10 nondiffusion weighted (b= 0 s/mm2) images and 2
non-zero b-values (900, 2000 s/mm2), each with 60 direc-
tions; TR/TE= 2400msec/66msec, 2.0mm3 isotropic
resolution, 256mm FOV, total scan time= 3:24min:sec.
All raw and processed data were visually inspected and
determined to be of good-to-excellent quality. Images
were aligned and registered to the MNI152 2mm3 stan-
dard space template (Montreal Neurological Institute,
Montreal, QB, Canada).
DTI and quantitative diffusion tractography. Diffusion-
weighted imageswere acquired and a total of 64 echoeswas
collected, with echo spacing of 0.78msec and a readout
bandwidth of 1490Hz/px, resulting in a total echo train
length of 84.42msec. DTI data were analyzed using the
TRACULA package, integrated in the Freesurfer Software
version 5.3, which reconstructs white matter pathways
usingglobal probabilistic tractography. First,weperformed
an automated reconstruction followed by automated label-
ing of cortical and subcortical regions on the anatomi-
cal T1-weighted images, which FMRIB Software Library
(FSL) performs based on probabilistic information from
a manually labeled training set. Next, in compliance
with standard TRACULA preprocessing procedures, we
applied FSL’s eddy-current correction algorithm to correct
for motion and eddy-current effects. For quality assess-
ment, four measures of head movement were calculated
from the diffusion weighted imaging (DWI) and the out-
put of the prior eddy-current correction procedures (aver-
age translation, average rotation, percent ‘‘bad’’ slices, and
percent dropout score). Any participant with >1.5mm of
moment (translation or rotation) or with >2% of bad sli-
ces or dropout was excluded. There was no signiﬁcant dif-
ference in motion between groups (all p’s> 0.10), and no
participants were excluded due to excessive motion. We
then performed an afﬁne registration of structural T1
images and diffusion tensors of each participant using
bbregister for intra-subject registration. Before diffusion-
to-template transformations, T1 images of all partici-
pants were registered to the MNI152 2mm3 standard
space template. Subsequently, tensors were estimated
and then mapped from diffusion space to MNI space.
TRACULA then applied the ball-and-stickmodel of diffu-
sion to the data and provided the reconstructed pathways.
In a last step, tracts were estimated and ﬁtted by combin-
ing the output of the ball-and-stick model and the atlas
data obtained frommanually labeled tracts. The ﬁnal out-
put for the bilateral UF was assessed for mean diffusion
(MD), radial diffusivity (RD), axial diffusivity, (AD),
and fractional anisotropy (FA), deﬁned as the fraction
of the magnitude of the tensor that is due to anisotropic
water diffusion. For each tract, we computed mean values
from all voxel across the tract, and determined ﬁber bun-
dle length. An illustration of the UF in all participants was
generated using TRACULA.
Cortical thickness. T1-weighted images were analyzed
using Freesurfer (Martinos Center for Biomedical Imag-
ing, Massachusetts General Hospital, Boston; http://
surfer.nmr.mgh.harvard.edu). Images were aligned and
registered to the MNI152 2mm3 standard space tem-
plate (with 0.7mm resolution) and corrected for spatial
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distortion and smoothed using an full width at half
maximum (FWHM) of 5mm.Whole brain segmentation
and cortical parcellation were applied to the corrected
T1-weighted images.46,47 We visually inspected processed
images and segmentations, and any errors in processing
were corrected using manual methods. The edited scans
were then reprocessed and cortical thickness data were
extracted from the corrected images. We examined cor-
tical thickness of six regions along the UF: medial OFC,
lateral OFC, fusiform gyrus, entorhinal cortex, temporal
pole, and inferior temporal pole. Measures of additional
brain volumes (e.g., amygdala and hippocampus) were
also extracted, but were not a primary focus of this report.
Statistical methods. Group differences in background
characteristics were assessed using Student’s t-tests in
SPSS version 19. All statistical tests were two tailed.
For memory performance data, we ran a multivariate
ANCOVA, including all memory variables as dependent
variables, group as an independent variable, and alcohol
as a covariate. For all structural data (diffusion and corti-
cal thickness), we ran a series of repeated-measures (RM)
ANCOVAs, using hemisphere as a repeated measure and
alcohol (drinks per week) and gender as covariates. In ad-
dition, we used intracranial volume as a covariate when
analyzing tract length, as tract length likely scales with
head size. These RM-ANCOVAs assessed for a group ef-
fect of CU versus CON, as well as a group·hemisphere
effect to determine if group differences were affected
by hemisphere. We used false discovery rate (q= 0.05)
to control for multiple comparisons48 among the six bi-
lateral structures assessed (medial OFC, lateral OFC,
fusiform gyrus, entorhinal cortex, temporal pole, and in-
ferior temporal pole), and for three diffusion measures
assessed bilaterally (FA, MD, and ﬁber bundle length).
We also calculated effect sizes of each region on each
side separately, using Cohen’s d. Signiﬁcant ANCOVAs
were followed by post-hoc Tukey’s honest signiﬁcant dif-
ference (HSD) tests to isolate effects. In any structural
measurement (DTI or cortical thickness) that showed a
signiﬁcant difference between CON and CU, we per-
formed Pearson correlations between the structural mea-
sure and memory performance.49 Data were checked for
normality and analyzed for outliers using the robust re-
gression and outlier removal (ROUT) method.49
Results
Participants
CU and controls did not signiﬁcantly differ in age, gen-
der, or years of education (Table 1). CU used cannabis
on an average of 2.70 (SD= 1.48) days per week and
1.66 (SD = 0.94) times per day, and smoked 5.87 (SD =
7.36) joints per week. The average duration of cannabis
use in CU was 4.37 (SD = 1.67) years. Recency of use
was 2.79 (SD = 3.10) days on average. There was a sig-
niﬁcant group difference in alcohol consumption per
week ( p = 0.04; CU: M = 3.03, SD = 2.14; CON: M =
1.90, SD= 2.33). Therefore, all analyses controlled for
alcohol use.
Memory performance
Across all recall measures of the CVLT-II (SDFR, SDCR,
LDRF, and LDCR), there was a signiﬁcant effect of
group (F4,36= 2.7, p= 0.038, Zp2= 0.23), indicating that
CU performed signiﬁcantly worse than CON across
these conditions (Fig. 2). Post-hoc tests indicated a sig-
niﬁcant difference in LDCR between CON and CU
(t= 2.05, p= 0.04, Cohen’s d= 0.66). For the other mem-
ory measures, CU generally performed worse than CON,
FIG. 2. California verbal learning task
performance. Bar plots show standardized CVLT
scores of CU and CON for each of four conditions:
SDFR, SDCR, LDFR, and LDCR. There was a
signiﬁcant effect of group across conditions, with
CU performing signiﬁcantly worse than CON
(F4.36)= 2.7, p= 0.04). A post-hoc analysis showed
that only LDCR was signiﬁcantly different between
groups. Effect sizes (Cohen’s d) are shown for each
condition. *Signiﬁcant differences between groups
using a multivariate ANCOVA (p< 0.05). CVLT,
California Verbal Learning Test; SDFR, short-delay
free recall; SDCR, short-delay cued recall; LDFR,
long-delay free recall; LDCR, long-delay cued recall.
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indicated by small to medium effect sizes, but between-
group differences were nonsigniﬁcant (SDFR: t= 1.49,
p = 0.14, Cohen’s d = 0.47; SDCR: t = 0.96, p = 0.34,
Cohen’s d = 0.31; LDFR: t = 1.25, p = 0.21, Cohen’s
d = 0.40). Additional measures of memory performance
were not signiﬁcantly different between groups (Supple-
mentary Table S1).
Quantitative tractography
Using RM ANCOVAs, we found that CON and CU did
not showany signiﬁcant differences in FA,meandiffusiv-
ity, RD, or AD of the UF through either a main effect of
group or a group·hemisphere interaction (all p> 0.10,
see Supplementary Table S2). For an illustration of the
UF in all participants, see Figure 1A. For ﬁber bundle
length, one CU participant was determined to be an
outlier and was therefore removed from analyses.
After controlling for intracranial volume, we observed
a main effect of group on UF bundle length (F= 4.27,
p= 0.04), which revealed that length was signiﬁcantly re-
duced in CU compared to CON (Fig. 1B). There was no
group·hemisphere interaction (F= 0.35, p= 0.55).
Cortical thickness
Using RM ANCOVAs, we investigated group differ-
ences in the six regions connected to the UF. In the fron-
tal extension, we found a signiﬁcant main effect of group
on the lateral OFC (F= 5.30, p= 0.027), but not the me-
dial OFC (F= 1.77, p= 0.19). In the middle segment, we
found signiﬁcant main effects of group on the fusiform
gyrus (F= 6.97, p= 0.01) and entorhinal cortex (F= 7.27,
p= 0.01). In the temporal segment, we found a signiﬁ-
cant main effect of group on the temporal pole
(F= 4.13, p= 0.049), but not the inferior temporal cortex
(F= 2.21, p= 0.15). After adjusting for false discovery
rate (q= 0.05), only the main effects on the middle seg-
ments (i.e., fusiform gyrus and the entorhinal cortex)
remained signiﬁcant. None of these regions showed sig-
niﬁcant group·hemisphere interactions (all p> 0.10).
See Table 2 for mean values and effect sizes. We further
investigated group differences in regions previously im-
plicated in cannabis use, such as the hippocampus, thal-
amus, and amygdala. Only the right amygdala was
signiﬁcantly different between CON and CU (F= 4.39,
p= 0.04) (Supplementary Table S3).
Associations between cannabis use, brain structure,
and memory performance
Age of ﬁrst use of cannabis was signiﬁcantly associated
with memory performance on LDCR (r2 = 0.29,
p= 0.016), indicating that individuals who had earlier
use performed worse than those with later onset of
use (Fig. 3A). Based on our previous analyses, we re-
stricted correlations to those structures that showed
signiﬁcant differences between groups: UF ﬁber bundle
length, cortical thickness of the entorhinal cortex, and
cortical thickness of the fusiform gyrus. Cortical thick-
ness in the left entorhinal cortex was signiﬁcantly cor-
related with age of ﬁrst use (r2 = 0.27, p = 0.02) (Fig. 3B)
and LDCR scores (r2 = 0.34, p = 0.009) (Fig. 3C). UF
ﬁber bundle length and cortical thickness of the fusi-
form gyrus were not associated with age of ﬁrst use
or with memory performance.
Discussion
Despite emerging evidence that cannabis use appears to
disrupt verbal memory and is associated with alterations
of brain structure, few studies have investigated whether
cannabis use is associated with altered white matter tracts
and cortical thickness in structures that support verbal
memory. Thus, this study investigated (1) verbal memory
performance in CU and controls, (2) white matter integ-
rity of the UF, and cortical thickness of the regions con-
nected to the UF that support verbal memory (e.g., the
OFC, entorhinal cortex, fusiform cortex, and temporal
poles), (3) how age of onset of cannabis use affected ver-
bal memory performance, and (4) associations between
verbal memory performance, morphometry, and age of
Table 2. Fiber Bundle Length and Cortical Thickness
of Regions Along the Uncinate Fasciculus
Region Hemi
Controls (22) CU (19)
Cohen’s dMean SD Mean SD
Fiber bundle lengtha Left 48.4 4.96 46.5 5.4 0.38
Right 45.40 4.65 42.50 2.94 0.75
Medial OFC Left 2.55 0.15 2.50 0.14 0.35
Right 2.50 0.15 2.41 0.13 0.65
Lateral OFCa Left 2.83 0.14 2.74 0.12 0.70
Right 2.72 0.15 2.6 0.15 0.82
Fusiform gyrusb Left 2.83 0.14 2.74 0.13 0.68
Right 2.90 0.11 2.81 0.11 0.84
Entorhinal gyrusb Left 3.60 0.32 3.44 0.43 0.44
Right 3.90 0.21 3.65 0.32 0.96
Temporal polea Left 3.90 0.32 3.73 0.21 0.63
Right 4.00 0.28 3.94 0.25 0.23
Inferior temporal gyrus Left 3.02 0.14 2.90 0.19 0.75
Right 3.01 0.14 2.93 0.19 0.50
Fiber bundle length, mean values, standard deviations, and effect
sizes of cortical thickness of regions along the UF.
aSigniﬁcant differences between groups using a repeated measures
ANCOVA.
bSigniﬁcant differences between groups after FDR correction.
CU, cannabis users; FDR, false discovery rate; UF, uncinate fasciculus;
OFC, orbitofrontal cortex.
Levar, et al.; Cannabis and Cannabinoid Research 2018, 3.1
http://online.liebertpub.com/doi/10.1089/can.2017.0030
61
initiation of cannabis use. Three main ﬁndings emerged
from this study. First, memory performance on delayed
recall (LDCR) was worse in CU than the CON group.
Second, UF ﬁber bundle length, as well as cortical thick-
ness of several prefrontal and temporal regions along the
UF, was reduced in CU. Third, age of onset of cannabis
use correlated with memory performance decrements.
In post-hoc analyses, we also found that decreased cortical
thickness was associated with age of onset of cannabis use
and verbal memory performance.
Emerging research has shown that cannabis use, par-
ticularly during adolescence, is associated with verbal
memory deﬁcits.50 This period of increased vulnerabil-
ity of verbal memory processes to cannabis exposure
may be due to the normal process of rapid development
of the endocannabinoid system that takes place during
adolescence.51,52 In this study, we observed that the CU
group performed worse on LDCR compared to CON,
and a younger age of onset of cannabis use was corre-
lated with poorer performance on LDCR. This result
is consistent with an emerging literature on the effects
of adolescent cannabis use2,53 and our prior work dem-
onstrating that delayed recall is compromised in young
adults with early-onset cannabis use (<16 years), com-
pared to young adults with late cannabis use onset
(>16 years) and control subjects.35 It is important to
note that our previous study demonstrated that weak-
nesses in delayed recall were fully mediated by weak-
nesses in encoding (e.g., Trial 1 learning) among
early-onset CU. We did not detect this effect in this
study, likely because of the smaller sample size and
the mixed age of ﬁrst use among our participants.
Verbal memory is supported by a wide range of brain
regions,20 including the prefrontal cortex and regions
within the temporal lobe. These regions are rich in can-
nabinoid CB1 receptors,54 which may render them vul-
nerable to cannabis-related alterations. Verbal memory
is also supported by white matter tracts such as the
UF, which serves a broad array of brain functions, in-
cluding memory (value-based updating of stored rep-
resentations), and language related to verbal memory
(retrieval of names; aspects of semantic memory re-
trieval).18 In this study, we observed that the CU group
had reduced measures of FA compared to CON that
were characterized by a medium effect size. However,
these differences did not attain statistical signiﬁcance.
A previous study found reductions in FA and MD in
the bilateral UF of regular CU,55 while other studies
have found signiﬁcant reductions in the FA and MD
in numerous other white matter tracts, including the
FIG. 3. (A) Age of ﬁrst cannabis use was positively
correlated with average standardized score on the
CVLT-II (r=0.59, p= 0.008). (B) Cortical thickness in
the left entorhinal cortex was signiﬁcantly
correlated with age of onset of cannabis use
(r= 0.53, p=0.02). (C) Cortical thickness in the left
entorhinal cortex was signiﬁcantly correlated with
average memory performance (r=0.58, p= 0.009).
Each point represents one participant, and the 95%
conﬁdence interval is depicted.
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arcuate fasciculus, and superior longitudinal fascicu-
lus.28,37,55 However, these cohorts generally had earlier
ages of cannabis use onset or longer duration of canna-
bis use than the participants in this study. The observed
group differences in these studies could indicate that al-
terations in FA and MD values may become more pro-
nounced with prolonged consumption and earlier onset
of use, or in older, more chronic CU. Alternatively, the
lack of signiﬁcance in this study could be explained by
limited statistical power due to the size of our study sam-
ple. We found that UF ﬁber bundle length was shorter in
CU compared to CON, which may indicate that ﬁber
bundle length may be related to lighter patterns of can-
nabis use. We did not detect associations between white
matter measurements and age of onset of use. It is im-
portant to note that white matter volume does not
reach its peak until adulthood, between the mid-30s
and 40s56–58; so it is possible that cannabis use could af-
fect UF development throughout life.
We found signiﬁcantly reduced cortical thickness in
CU compared to CON in the entorhinal cortex and fusi-
form gyrus, which are regions connected by the UF18,19
and known to support verbal memory.20 To our knowl-
edge, studies have not yet investigated cannabis use and
cortical thickness in these temporal regions. The ento-
rhinal and fusiform cortices are dense with CB1 recep-
tors, and therefore, this ﬁnding is consistent with
studies reporting reduced cortical thickness in other
regions dense in CB1 receptors, such as the prefrontal
cortex.25 Moreover, we found that the entorhinal cor-
tex was associated with memory performance and age
of onset of cannabis use. Although the entorhinal cor-
tex is generally not as well studied as regions such as
the hippocampus or prefrontal cortex for memory func-
tion, there is literature suggesting role for the entorhinal
cortex in memory. For example, in a study of healthy
adults, longitudinal changes in entorhinal cortex volumes
were shown to predict verbal memory performance.59
However, it is important to note that the association
reported in this study was found in a small sample
size, and should therefore be replicated in larger samples.
In conclusion, this study reports signiﬁcant group
differences between CU and CON in verbal memory
performance and brain-based structural measures of
the UF, and cortical thickness in several of its connect-
ing regions. Results of this study should be interpreted
cautiously. First, as with all cross-sectional studies, ef-
fects described could have been pre-existing, a result
of cannabis use, or a combination of both. Second,
our participants used alcohol, which is a common con-
founding factor in magnetic resonance imaging (MRI)
studies of cannabis exposure. Thus, we controlled for al-
cohol consumption in our statistical analyses; however,
future studies could attempt to match participants for al-
cohol use measures. To this end, we caution that corre-
lations between LCDR performance and cortical
thickness may not be speciﬁc to cannabis use. Third,
the small sample size limits our ability to conduct de-
tailed subanalyses (e.g., analyses based on early and
late cannabis use onset, gender, or frequency/duration
of use), and we likely had limited power to detect mem-
ory performance effects in encoding. Fourth, there may
have been methodological limitations to this study (e.g.,
the analysis could not control for all brain inhomogene-
ity artifacts). Last, as cannabis remains in the system for
up to a month, it is possible that the reported effects on
memory are due to recent cannabis use. Thus, the ob-
served group differences could be, in part, explained
by residual effects of circulating cannabis metabolites
in the CU group. Future studies can examine how the
above factors relate to group differences between CU
and CON. Furthermore, future research can also extend
investigations to other white matter tracts to more thor-
oughly understanding the impact of cannabis exposure
on the human brain and its potential effects on cognitive
processing.
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CB1¼ cannabinoid
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DTI¼ diffusion tensor imaging
FA¼ fractional anisotropy
LDCR¼ long delayed cued recall
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MD¼mean diffusion
OFC¼ orbitofrontal cortex
RD¼ radial diffusivity
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SDCR¼ short delayed cued recall
SDFR¼ short delayed free recall
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